Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.
2.
3.

Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.

Kil WJ, Kulasekere C, Hatch C, Bugno J, Derrwaldt R.

Head Neck. 2017 Aug;39(8):E85-E91. doi: 10.1002/hed.24809. Epub 2017 May 5.

PMID:
28475284
6.

Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation.

Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K.

Eur J Cancer. 2013 Sep;49(14):3020-8. doi: 10.1016/j.ejca.2013.05.013. Epub 2013 Jun 18.

7.

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.

Kil WJ, Nichols RC Jr, Hoppe BS, Morris CG, Marcus RB Jr, Mendenhall W, Mendenhall NP, Li Z, Costa JA, Williams CR, Henderson RH.

Acta Oncol. 2013 Apr;52(3):492-7. doi: 10.3109/0284186X.2013.767983.

8.

Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report.

Kil WJ, Nichols RC Jr, Kilkenny JW, Huh SY, Ho MW, Gupta P, Marcus RB, Indelicato DJ.

Radiat Oncol. 2012 Oct 26;7:178. doi: 10.1186/1748-717X-7-178.

9.

Radiosensitization by the novel DNA intercalating agent vosaroxin.

Gordon IK, Graves C, Kil WJ, Kramp T, Tofilon P, Camphausen K.

Radiat Oncol. 2012 Feb 27;7:26. doi: 10.1186/1748-717X-7-26.

10.

Post-radiation increase in VEGF enhances glioma cell motility in vitro.

Kil WJ, Tofilon PJ, Camphausen K.

Radiat Oncol. 2012 Feb 22;7:25. doi: 10.1186/1748-717X-7-25.

11.

High throughput evaluation of gamma-H2AX.

Avondoglio D, Scott T, Kil WJ, Sproull M, Tofilon PJ, Camphausen K.

Radiat Oncol. 2009 Aug 24;4:31. doi: 10.1186/1748-717X-4-31.

12.

Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis.

De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K.

Cell Cycle. 2009 Jul 1;8(13):2093-100. Epub 2009 Jul 5.

13.

Bronchoalveolar lavage findings of radiation induced lung damage in rats.

Park KJ, Oh YT, Kil WJ, Park W, Kang SH, Chun M.

J Radiat Res. 2009 May;50(3):177-82. Epub 2009 Apr 18.

14.

Chemotherapy-related amenorrhea in premenopausal women with breast cancer.

Lee S, Kil WJ, Chun M, Jung YS, Kang SY, Kang SH, Oh YT.

Menopause. 2009 Jan-Feb;16(1):98-103. doi: 10.1097/gme.0b013e3181844877.

PMID:
18849877
15.

In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.

Kil WJ, Cerna D, Burgan WE, Beam K, Carter D, Steeg PS, Tofilon PJ, Camphausen K.

Clin Cancer Res. 2008 Feb 1;14(3):931-8. doi: 10.1158/1078-0432.CCR-07-1856.

16.

Geometric shifting of the porta hepatis during posthepatectomy radiotherapy for biliary tract cancer.

Kil WJ, Kim DY, Kim TH, Park SJ, Kim SH, Park KW, Lee WJ, Shin KH, Park JW.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):212-6. Epub 2006 Jun 21.

PMID:
16793215
17.

Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients.

Kil WJ, Ahn SD, Shin SS, Lee SW, Choi EK, Kim JH, Son BH, Ahn SH, Kim WK, Kim SB.

Breast Cancer Res Treat. 2006 Apr;96(3):245-50. Epub 2006 Mar 23.

PMID:
16555128

Supplemental Content

Loading ...
Support Center